Director's Dealing • Mar 10, 2020
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 5828F
Hammerson PLC
10 March 2020
10 March 2020
The Company was notified on 9 March 2020 that David Tyler, Chair of the Board of the Company, has acquired ordinary shares of 25 pence each (Shares) as follows:
| Date of purchase | Number of Shares acquired | Share price £ |
| 9 March 2020 | 25,000 | 1.70982 |
| 9 March 2020 | 25,000 | 1.70744 |
This announcement is made in accordance with the requirements of the EU Market Abuse Regulation. The notification of dealing form can be found below.
The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.
Richard Crowle
Assistant Company Secretary
+44 (0) 20 7887 1000
Notification of dealing form
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
David Tyler
2
Reason for the notification
a)
Position/status
Chair of the Board
b)
Initial notification
/Amendment
Initial notification
3
Details of the issuer
a)
Name
Hammerson plc
b)
LEI
213800G1C9KKVVDN1A60
4
Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument.
Identification code
Ordinary shares of 25 pence each
ISIN: GB0004065016
b)
Nature of the transaction
Purchase of ordinary shares of 25 pence
c)
Price(s) and volume(s)
| Price(s) | Volume(s) | |
| £1.70982 | 25,000 | |
| £1.70744 | 25,000 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total | |
| £1.709 | 50,000 | £85,431.50 |
e)
Date of the transaction
9 March 2020
f)
Place of the transaction
XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHEANDEFSSEEEA
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.